Deep Tech Moats: Building for the Decade, not the Demo

Few months ago, I watched a quantum computing startup deliver a slick 10-minute pitch that had the room buzzing. Beautiful slides, crisp messaging, and a demo that made quantum supremacy look like child’ play. Two weeks later, I backed their competitor - a team of PhDs whose presentation was a disaster but whose technical depth made my head spin. The difference? One was building for the demo day; the other was building for the decade.

This distinction matters more than ever.

When AI companies dominate headlines with OpenAI’s $60B in funding, the real alpha lies in the unglamorous corners of deep tech where technical moats take years to build and decades to breach. These are the companies that will define the next technological epoch, not the next funding cycle.

The venture capital world has developed an unfortunate bias toward what I call “demo-able” technology.

“If you can’t explain it in 30 seconds and show it working on stage, it’s too hard to fund.”

This creates a systematic underinvestment in the most important technological developments of our time. Consider the quantum computing landscape. Quantum startups raised $1.9 billion in 2024, a 138% jump from the previous year, but most of this capital went to companies promising near-term quantum advantage in software optimization. Meanwhile, the teams building actual quantum hardware - the foundational layer that will determine winners and losers - struggle to raise meaningful rounds because their timelines extend beyond typical fund lifecycles.

The same dynamic plays out across deep tech verticals. In biotech, Xaira Therapeutics raised $1B and Metsera raised over $500M, but these are exceptional cases. Most deep biology companies working on fundamental problems like protein folding or cellular reprogramming can’t generate the kind of traction metrics that excite growth-stage investors.

After evaluating hundreds of deep tech companies across quantum, biotech, robotics, and advanced materials, I’ve identified three types of moats that actually hold water:

1. Physics-Based Moats

These are the strongest moats in deep tech because they’re literally governed by the laws of physics. Take quantum error correction - the companies that solve this fundamental problem first won’t just have a competitive advantage; they’ll have a monopoly on practical quantum computing.

IonQ, despite trading volatility, represents the category well. while other quantum SPACs like Rigetti and D-Wave lost over 90% of their value, IonQ’s trapped-ion approach offers fundamental advantage in error rates that software can’t solve around. The physics constraints the competition.

Similarly, in biotech, companies like Qubit Pharmaceuticals are building quantum-classical hybrid systems for drug discovery. This isn’t just better software - it’s accessing computational spaces that classical computers literally cannot reach.

2. Data Network Effects

The second tier involves companies that create proprietary data sets that improve with scale. These are harder to build but easier to understand form a business model perspective.

Look at synthetic biology companies working on protein design. Each iteration generates data that improves the next iteration, creating a compounding advantage.

Data network effects often take 3-5 years to manifest. Traditional metrics like monthly active users or annual recurring revenue miss the accumulating value of these proprietary datasets.

3. Regulatory Capture

The third category involves companies that turn regulatory complexity into competitive advantage. This is particularly relevant in areas like nuclear energy, aerospace and advanced manufacturing where regulatory approval becomes a moat.

The companies that invest early in regulatory relationships and compliance infrastructure create barriers that are nearly impossible for competitors to overcome quickly. It’s nor just about having the best technology - it’s about having the best relationship with the agencies that decide whether your technology can be deployed.

One of the most compelling aspects of deep tech investing is the talent arbitrage. While every MBA wants to start a SaaS company, the number of people capable of building quantum error correction algorithms or engineering synthetic biology platforms is quite small.

This creates a unique dynamic where technical depth becomes a moat in itself. The most successful startups that I’ve backed share a common trait: their founders are the only people on the planet who could have built what they built. This isn’t just technical knowledge - it’s the intersection of deep domain expertise, engineering capability, and business vision that takes decades to develop.

Deep Tech investing requires reframing your entire approach to company building. Instead of the traditional “18 months to Series A” timeline (or even shorter now with AI disrupting this cadence), you’re looking at 3-5 years to proof of concept and 7-10 years to meaningful revenue.

This timeline mismatch creates systematic opportunities for investor willing to embrace longer development cycles. Also the approach you take towards diligence is different. Instead of customer reference calls, you’re talking to Nobel laureates. Instead of market sizing, you’re modelling physics constraints, and instead of growth metrics, you’re tracking milestones.

The key is distinguishing between companies that are slow because they’re inefficient and companies that are slow because they’re solving hard problems.

In the end, the companies that survive the decade-long development cycles don’t just succeed - they become infrastructure for the next generation of innovation. And for investors willing to embrace this timeline, the opportunities are extraordinary.

The views expressed are those of the author and do not necessarily reflect the views of any investment firm or portfolio company.